Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Saving Salt: Delineating the Salt Wasting Phenotype in dRTA Patients

FY 2022-23

Summary
Kidney disease is the 10th leading cause of death in Canada. The diseases can arise from disturbances in the prominent functions of kidney’s collecting ducts: acid base and electrolyte balance. The kidney collecting duct contains intercalated cells (ICs; Type A and Type B), which function to maintain acid-base balance and salt reabsorption in our bodies. Mutations in the genes responsible for proper function of A-ICs can cause a disease called distal renal tubular acidosis (dRTA). dRTA patients experience acidic blood, basic urine, kidney stones, and salt (NaCl) loss in the urine. Intriguingly, even after sustained treatment of their dRTA, human patients continue losing NaCl in their urine. Our lab has two dRTA mouse models which mimic human dRTA patients, suitable to study this phenomenon. These mice, like dRTA patients, have a decreased abundance of A-ICs. Given this, we hypothesize that the urinary loss of NaCl in dRTA occurs due to lesser number of A-ICs associated with the disease. To investigate this, our wildtype (WT) and dRTA mutant mice will be fed a low salt diet and/or an acid diet, to mimic dRTA. Their plasma, urine, and feces will be collected to measure and compare ion and hormone levels. mRNA and protein abundance of A-IC markers and collecting duct salt transporters will be measured from their kidney tissues. We expect to see a less A-ICs and increased urinary NaCl in the dRTA mutant mice compared to WT. Potential compensatory mechanisms, like upregulation of salt transporters in other kidney sections, will also be investigated to potentially explain the pathophysiology of these patients. This project is a unique approach to understanding salt reabsorption, which can lead to better treatments for dRTA patients and individuals with electrolyte imbalances.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
485964
Name
Mungara Priyanka
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Saving Salt: Delineating the Salt Wasting Phenotype in dRTA Patients
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Animal Studies; Disease Treatment; Genetic Mutations; Kidney Stone; Membrane Transporters; Metabolic Cages; Molecular And Protein Biology; Renal Physiology; Renal Tubular Acidosis; Salt Balance
Abstract
Kidney disease is the 10th leading cause of death in Canada. The diseases can arise from disturbances in the prominent functions of kidney’s collecting ducts: acid base and electrolyte balance. The kidney collecting duct contains intercalated cells (ICs; Type A and Type B), which function to maintain acid-base balance and salt reabsorption in our bodies. Mutations in the genes responsible for proper function of A-ICs can cause a disease called distal renal tubular acidosis (dRTA). dRTA patients experience acidic blood, basic urine, kidney stones, and salt (NaCl) loss in the urine. Intriguingly, even after sustained treatment of their dRTA, human patients continue losing NaCl in their urine. Our lab has two dRTA mouse models which mimic human dRTA patients, suitable to study this phenomenon. These mice, like dRTA patients, have a decreased abundance of A-ICs. Given this, we hypothesize that the urinary loss of NaCl in dRTA occurs due to lesser number of A-ICs associated with the disease. To investigate this, our wildtype (WT) and dRTA mutant mice will be fed a low salt diet and/or an acid diet, to mimic dRTA. Their plasma, urine, and feces will be collected to measure and compare ion and hormone levels. mRNA and protein abundance of A-IC markers and collecting duct salt transporters will be measured from their kidney tissues. We expect to see a less A-ICs and increased urinary NaCl in the dRTA mutant mice compared to WT. Potential compensatory mechanisms, like upregulation of salt transporters in other kidney sections, will also be investigated to potentially explain the pathophysiology of these patients. This project is a unique approach to understanding salt reabsorption, which can lead to better treatments for dRTA patients and individuals with electrolyte imbalances.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mungara, Priyanka
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~